Abstract

Durable mechanical circulatory support is increasingly being utilised for patients with end-stage heart failure, with good long-term outcomes. However, the options for durable biventricular support remain limited, with the SynCardia total artificial heart being the only world-wide approved device, albeit with well documented limitations. This abstract discusses animal work with two upcoming durable biventricular assist devices.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call